Doxycycline Hyclate Tablet, Delayed Release shortage
Doxycycline Hyclate Tablet, Delayed Release is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 22, 2026.
Teva is permanently stopping its doxycycline hyclate delayed-release tablets (50 mg and 200 mg), and no supply from Teva remains. Other makers still list doxycycline hyclate delayed-release tablets at 75 mg, plus regular doxycycline hyclate tablets at 100 mg.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Doxycycline Hyclate Tablet, Delayed Release. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jul 30, 2026Currently in shortage2 of 2 products affected.
-
Jul 30, 2026First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Doxycycline Hyclate Tablet, Delayed Release — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Doxycycline Hyclate Tablet, Delayed Release? options further down this page.
Why is Doxycycline Hyclate Tablet, Delayed Release in shortage?
Teva Pharmaceuticals has decided to permanently stop making two specific versions of delayed-release doxycycline hyclate tablets: the 50 mg tablets (NDC 0591-4550-22) and the 200 mg tablets (NDC 0591-4575-60). This is a permanent decision, not a temporary shortage — they are fully discontinuing production of both of these products. Teva did not share a specific public reason for why they made this business decision.
It's worth knowing that this report reflects only what Teva has filed with the FDA about their products. Other manufacturers of delayed-release doxycycline hyclate are covered separately, so this does not necessarily mean the medication is going away from the market entirely.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Doxycycline Hyclate Tablet, Delayed Release, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Doxycycline Hyclate Tablet, Delayed Release?
Doxycycline hyclate delayed-release tablets are currently on the FDA shortage list. I want to walk you through what this means and the practical steps you can take.
Both strengths on this record — the 50 mg and the 200 mg delayed-release tablets — have no available source reported right now. The reason listed for both is that the manufacturer (Teva) is discontinuing production. Because this is a discontinuation rather than a temporary supply gap, this particular product may not return, so a conversation with your prescriber is the right next step.
It's worth knowing that this report reflects only the manufacturer who filed it. The same medicine, doxycycline hyclate delayed-release, is still on the market from another maker (Heritage/Avet) in several strengths, including a 200 mg delayed-release tablet. Your pharmacy may be able to source one of these, though it may not be in local stock.
Here is what I suggest:
- Do not stop or change your dose on your own — keep taking it as prescribed while you sort this out.
- Ask your pharmacy to check wholesalers and other manufacturers for the same medicine.
- Ask your prescriber or pharmacist about a clinician-chosen option or a strength that matches your dose.
Manufacturer contact numbers are listed on this page for reference; your pharmacy usually handles those calls.
This is general, national information and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Doxycycline Hyclate Tablet, Delayed Release?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Doxycycline Hyclate Tablet, Delayed Release is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE 100 mg/1 | Tablet, Coated · Oral | Hikma Pharmaceuticals USA Inc. | 00143-2112-05 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE 100 mg/1 | Tablet | Actavis Pharma, Inc. | 00591-5553-00 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE 100 mg/1 | Tablet, Coated · Oral | Major Pharmaceuticals | 00904-0430-04 |
| Doxycycline Hyclate Delayed Release | DOXYCYCLINE HYCLATE 75 mg/1 | Tablet, Delayed Release · Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0141-01 |
| Doxycycline Hyclate Delayed Release | DOXYCYCLINE HYCLATE 100 mg/1 | Tablet, Delayed Release · Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0142-01 |
| Doxycycline Hyclate Delayed Release | DOXYCYCLINE HYCLATE 150 mg/1 | Tablet, Delayed Release · Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0143-01 |
| Doxycycline Hyclate Delayed Release | DOXYCYCLINE HYCLATE 200 mg/1 | Tablet, Delayed Release · Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0611-04 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE 100 mg/1 | Tablet, Film Coated · Oral | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-0310-01 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE 75 mg/1 | Tablet · Oral | Ajanta Pharma USA Inc. | 27241-0153-02 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE 150 mg/1 | Tablet · Oral | Ajanta Pharma USA Inc. | 27241-0154-02 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE 100 mg/1 | Tablet · Oral | Cranbury Pharmaceuticals, LLC | 27808-0234-01 |
| Doxycycline | DOXYCYCLINE HYCLATE 100 mg/1 | Tablet, Coated · Oral | Acella Pharmaceuticals, LLC | 42192-0501-05 |
Alternative dosage forms of Doxycycline Hyclate Tablet, Delayed Release
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 8 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Doxycycline Hyclate 50 mg | Actavis | 120 tablets | $1.569 | AB | Availability likely |
| Doxycycline Hyclate 50 mg | Solco | 120 tablets | $1.569 | AB | Availability likely |
| Doxycycline Hyclate 200 mg | Actavis | 60 tablets | $3.701 | AB | Availability likely |
| Doxycycline Hyclate 200 mg | Solco | 60 tablets | $3.701 | AB | Availability likely |
| Doxycycline Hyclate 200 mg | Mayne | 30 tablets | $3.701 | — | Availability likely |
| Doxycycline Hyclate Delayed Release 200 mg | Heritage | 250 tablets | — | AB | FDA listed |
| Doxycycline Hyclate 200 mg | Alembic | 100 tablets | — | AB | FDA listed |
| Doxycycline Hyclate 200 mg | Alembic | 30 tablets | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Doxycycline Hyclate Tablet, Delayed Release — that fall in the same broad treatment class (tetracycline antibiotics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other anti-infective shortages
Doxycycline Hyclate Tablet, Delayed Release shortage FAQs
Is Doxycycline Hyclate Tablet, Delayed Release in shortage?
Which products are affected?
When will Doxycycline Hyclate Tablet, Delayed Release be available again?
Can I still get Doxycycline Hyclate Tablet, Delayed Release somewhere?
What should I do if I take Doxycycline Hyclate Tablet, Delayed Release?
Still have a question about the Doxycycline Hyclate Tablet, Delayed Release shortage?
Ask a pharmacist about this shortage →View Doxycycline Hyclate Tablet, Delayed Rele... on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.